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Two sampling methods yield distinct
microbial signatures in the nasopharynges
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Abstract
Background: The nasopharynx is a reservoir for pathogens associated with respiratory illnesses, such as asthma.
Next-generation sequencing (NGS) has been used to characterize the nasopharyngeal microbiome during health
and disease. Most studies so far have surveyed the nasopharynx as a whole; however, less is known about spatial
variation (biogeography) in nasal microenvironments and how sampling techniques may capture that microbial
diversity.
Findings: We used targeted 16S rRNA MiSeq sequencing and two different sampling strategies [nasal washes (NW)
and nasal brushes (NB)] to characterize the nasopharyngeal microbiota in 30 asthmatic children. Nasal brushing is
more abrasive than nasal washing and targeted the inner portion of the inferior turbinate. This region is expected
to be different from other nasal microenvironments. Nasal washing is not spatially specific. Our 30 × 2 nasal
microbiomes generated 1,474,497 sequences, from which we identified an average of 157 and 186 OTUs per
sample in the NW and NB groups, respectively. Microbiotas from NB showed significantly higher alpha-diversity
than microbiotas from NW. Similarly, both nasal microbiotas were distinct from each other (PCoA) and significantly
differed in their community composition and abundance in at least 9 genera (effective size ≥1 %).
Conclusions: Nasopharyngeal microenvironments in asthmatic children contain microbiotas with different diversity
and structure. Nasal washes and brushes capture that diversity differently. Future microbial studies of the
nasopharynx need to be aware of potential spatial variation (biogeography).
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Findings
Background
The nasopharynx is considered an anatomical reservoir
from which pathogenic microbes can spread to the lower
and upper respiratory airways and cause respiratory infec-
tions [1–3]. Culture-independent sequencing methods have
shown that some pathogenic bacterial genera associated
with asthma (e.g., Moraxella, Streptococcus, Haemophilus,
Neisseria, and Staphylococcus) are also present in the
nasopharynx [1, 4–6]. Consequently, several recent meta-
taxonomic and metagenomic (see [7] for distinction)
studies have investigated how nasopharyngeal microbial
communities change during health and disease in relation
to clinical variation [1, 3, 5, 8–16]. All these next-
generation sequencing (NGS) studies, however, either sam-
pled the nasopharynx as a whole or focused on a particular
anatomical area (microenvironment); hence, less is known
about the spatial variation (biogeography) in microbial
composition of the nasopharynx. The nose has a compli-
cated and diverse anatomical structure, comprised of di-
verse epithelial cells and glands with different physiologies
and functions [17, 18]. Hence, it seems reasonable to expect
that different microenvironments in the nose will also har-
bor distinct microbial communities. However, to our
knowledge, only one study has assessed the biogeography
of the nasal microbiota [19]. In that study, the authors
used 16S rRNA sequence data to compare the microbiotas
of three nasal sites (anterior naris, middle meatus, and
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sphenoethmoidal recess) in healthy subjects and detected
significant differences in diversity between the anterior
nares and the two inner mucosal sites. No study, so far,
has investigated the biogeography of the nasal cavity in
asthmatic patients.
In this report, we used targeted 16S rRNA sequencing
and two different sampling techniques (nasal washes and
nasal brushes) to characterize the nasopharyngeal micro-
biota in asthmatic children. Nasal brushing is more abra-
sive than nasal washing and was used to target a
particular region of the nasopharynx, the inner portion of
the inferior turbinate; nasal washing is assumed to be less
spatially specific and to reach the main cavities in the
nasopharynx. Hence, given these differences in sampling
methodology, we hypothesize that nasal microbiotas col-
lected by nasal washes will be different in alpha- and beta-
diversity from those collected by nasal brushes.
Methods
Ethics approval and consent to participate
All participants in this study were part of the AsthMaP2
(Asthma Severity Modifying Polymorphisms) Study [20].
AsthMaP2 is an ongoing study of urban children and ad-
olescents designed to find associations among airway
microbes, environmental exposures, allergic sensitivities,
genetics, and asthma. AsthMaP2 and the study presented
here were approved by the Children’s National Medical
Center Institutional Review Board (Children’s National
IRB), which requires that consent is obtained and docu-
mented prior to conducting study procedures and collec-
tion of samples for research. Written consent was
obtained from all independent participants or their legal
guardians using the Children’s National IRB approved
informed consent documents (IRB No PRO00002517).
Samples and molecular analyses
A total of 30 children and adolescents (ages 6 to 17 years)
were recruited from the metropolitan Washington, DC,
area. All had been physician-diagnosed with asthma for at
least one year prior to recruitment. Individuals who re-
ported a medical history of chronic or complex cardiore-
spiratory disease were ineligible. Their nasopharynges
were simultaneously sampled using both nasal washes
(NW) and nasal brushes (NB). NW samples were pro-
cured by instilling 5 ml of isotonic sterile saline buffer into
each nare, holding it for 10 s, and then blowing into a
specimen collection container. NB samples were procured
by brushing the mucosa of the inner section of the inferior
turbinate of each nostril with a sterile nylon bristle
cytology brush (CytoSoft Cytology Brush No. CYB-1,
Medical Packaging Corporation Camarillo, CA). That
mucosa is covered with a mucus blanket that traps smaller
particulate matter and bacteria [21]. Moreover, cytology
brushes are designed to harvest epithelial cells, meaning
NB sampling is generally more abrasive than NW sam-
pling, and so, more likely to collect the microorganisms
closely attached to the nasal mucosa. Nonetheless, since
the cytology brushes are not protected, we cannot ensure
that these samples represent the inferior turbinate micro-
bial community alone, and it is possible that upon removal
of the brush from the sinuses, unintended mucus, hair,
and epithelial cells from the nares were also collected.
Nasal washes are non-specific and may target a different
microbial population than nasal brushes, which will pick
up microbes attached to the mucosal surface instead of
non-attached microbes along the sinonasal cavity (includ-
ing the inferior turbinate).
Total DNA was extracted using the QIAGEN QIAamp
DNA Kit (Catalog # 51304). Before adding the ATL buffer,
samples were pre-incubated in 100 uL of lysozyme-TE
buffer pH = 8.0 for 30 min at 37 °C. All extractions yield-
ing >50 ng of total DNA (as indicated by NanoDrop 2000
UV-vis Spectrophotometer measuring) were further proc-
essed. DNA extractions were prepared for sequencing using
the Schloss’ MiSeq_WetLab_SOP protocol (09.2015) in
Kozich et al. [22]. Each DNA sample was amplified for the
V4 region (~250 bp) of the 16S rRNA gene, and libraries
were sequenced using the Illumina MiSeq sequencing
platform at University of Michigan Medical School.
Sequence analyses
Raw FASTQ files were processed in mothur v1.35.1 [23].
Default settings were used to minimize sequencing er-
rors as described in Schloss et al. [24]. Clean sequences
were aligned to the SILVA_v123 bacterial reference
alignment at www.mothur.org. Chimeras were removed
using uchime [25], and non-chimeric sequences were
classified using the naïve Bayesian classifier of Wang et
al. [26]. Sequences were clustered into Operational
Taxonomic Units (OTUs) at the 0.03 threshold (species
level). OTU sequence representatives and taxonomy
were imported (BIOM format) into QIIME [27] for sub-
sequent analyses. The mothur OTU table was filtered to
a minimum of two observations (sequences) per OTU.
Samples were subsampled (rarefaction analysis) to the
smallest sample size (1,100 sequences) to remove the ef-
fect of sample size bias on community composition.
Nonetheless, OTU differential abundance tests that take
advantage of full sample sizes (metagenomeSeq zero-
inflated Gaussian [28]) were also applied for comparison.
Trees for phylogenetic diversity calculations were con-
structed using FastTree [29]. Taxonomic alpha-diversity was
estimated as the number of observed OTUs and by the
Chao1, Simpson, and Shannon indexes. Phylogenetic alpha-
diversity (PD) was calculated by the Faith’s phylogenetic
diversity index [30]. Similarly, both taxonomic (Bray-Curtis
and Euclidean) and phylogenetic (unweighted and weighted
UniFrac) beta-diversity metrics were calculated. Community
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dissimilarity was estimated using principal coordinates ana-
lysis (PCoA). Alpha- and beta-diversity metrics were com-
pared between samples grouped by sampling strategy (NW
versus NB) using both parametric and non-parametric ver-
sions of the t test. Taxonomic and phylogenetic distances
were also compared among those groups using the non-
parametric PERMANOVA test from the vegan R’s library
[31]. Significance was determined through 10,000 permuta-
tions. Finally, OTU abundance differences between NW
and NB groups and between paired samples (e.g., NW
patient 1 versus NB patient 1) were assessed using rarefied
(White’s non-parametric t test [32] and Fisher’s exact test,
respectively) and non-rarefied (metagenomeSeq zero-inflated
Gaussian) data. Core microbiome analyses were also
performed to identify resident bacteria. Bonferroni or
Benjamini-Hochberg FDR multiple test correction methods
were applied. All analyses were performed in mothur,
QIIME, STAMP [33], and RStudio [34].
Availability of the data and materials
Sequence data have been uploaded to the GenBank
under SRA accession number SRP069020. All materials
used for nasal brushing and washing were processed as
regular samples using the same QIAGEN DNA purifica-
tion kit and PCR protocols. No PCR band was visible on
an agarose gel.
Fig. 1 Taxonomic profiles of most abundant bacterial genera (OTU proportion >0.1 %) in 60 nasopharyngeal microbiomes from 30 asthmatic
children. NW nasal wash, NB nasal brush
Fig. 2 Box plots of alpha-diversity indices (Chao1 and phylogenetic diversity) comparing nasal wash (NW) and nasal brush (NB) samples
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Results
Sequences and OTUs
Sixty nasal microbiomes corresponding to 30 asthmatic
children were analyzed via MiSeq sequencing of 16S rRNA
V4 amplicons. A total of 1,474,497 sequences ranging from
1100 to 62,148 sequences per sample (mean = 24,575; me-
dian = 20,599) were obtained after quality control analyses
and OTU filtering. From these data, we identified 33–272
OTUs (mean = 157) per sample in the NW group and
120–408 OTUs (mean = 186) per sample in the NB group.
Microbial composition of the nasopharynx
Nasopharyngeal microbiomes were dominated by the fol-
lowing seven genera, which showed different proportions
in NW and NB groups: Moraxella (NW= 38.1 %, NB =
27.8 %), Staphylococcus (NW= 15.4 %, NB = 10.2 %),
Corynebacterium (NW= 8.6 %, NB = 20.4 %), Haemophilus
(NW= 8.4 %, NB = 4.2 %), Fusobacterium (NW= 5.8 %,
NB = 1.1 %), Prevotella (NW= 3.8 %, NB = 1.1 %), and
Dolosigranulum (NW= 3.7 %, NB = 8.7 %) (see Fig. 1). The
core microbiome analysis (OTUs present in 95 % of the
samples) identified five OTUs of the genera Moraxella,
Staphylococcus, Haemophilus, Streptococcus, and Entero-
coccus in NB and four OTUs of the genera Moraxella,
Pseudomonas, Enterococcus, and Bacteroides in NW. This
suggests that NW and NB may contain different resident
bacteria. All dominant genera reported here for asthmatic
children and adolescents have been detected in other
microbiome studies of the nasopharynx in infants with and
without respiratory infections [1, 3, 16, 35], although in
Fig. 3 3D principal coordinates analysis (unweighted UniFrac distances) of nasal wash (NW) and nasal brush (NB) samples
Fig. 4 Extended error bar plot showing the nine bacterial genera with a significant difference (White’s test; P < 0.05) in proportions of at least 1 %
between nasal wash (NW) and nasal brush (NB) samples. Seven genera are overabundant within the nasal microbiotas collected by washing
compared to those collected by brushing
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different proportions. Similarly, microbial profiles observed
in our children also looked different from those described
in the nasopharynx of adults [19, 36, 37].
Nasopharyngeal washes and brushes sampled different
microbiotas
Microbial profiles of the most abundant bacterial genera
(Fig. 1) and alpha-diversity indices (observed OTUs, Chao1,
Shannon, Simpson, and PD) varied greatly between NW
and NB groups (Fig. 2), with NB showing greater estimates
for all indices. These differences were significant in all cases
(non-parametric t test; P < 0.001). A previous NGS 16S
metataxonomic study of nasopharyngeal microenviron-
ments showed higher alpha-diversity values (same indices
as here) in microbiotas from the posterior sections of the
nasopharynx (represented by the middle meatus and sphe-
noethmoidal recess) than in those from the anterior naris
[19]. In accordance with their results, we also see a similar
trend in microbiotas mainly collected from the inferior
turbinate (NB) compared to those non-specifically sampled
along the sinonasal cavity (NW).
Beta-diversity ordination analysis of PCoA showed
clear dissimilarities between NW and NB microbiomes
for all distances tested (Fig. 3). Similarly, significant
differences (P < 0.001; R2 = 0.072) in community com-
position (PERMANOVA) were observed between both
groups after FDR correction. Finally, microbial abun-
dances also significantly varied between NW and NB
groups (White’s test; effect size ≥1 % and metagenome-
Seq zero-inflated Gaussian) after FDR correction for
the following nine genera: Staphylococcus, Prevotella,
Treponema, Streptococcus, Moraxella, Haemophilus,
Fusobacterium, Bacteroides, and Pseudomonas (Fig. 4).
Similarly, all 30 comparisons of paired samples showed
significant differences for 3 to 26 OTUs (Fisher’s exact
test with an effective size filter of ≥1 %). As above,
PCoA analysis in Yan et al. [19] also revealed a separ-
ation between anterior nare samples and more poster-
ior mucosal samples. Their ANOVA testing of OTU
relative abundances between those two regions de-
tected 18 OTUs that significantly differed between
them, although 16 of those relative abundances were
<0.1 %. Our analyses showed larger differences in com-
munity composition between nasal washes and nasal
brushes from potentially different environments in the
nasopharynx.
We believe that the observed differences in alpha- and
beta-diversity are due to the fact that our brushes tapped
on a richer microbial microenvironment in the nasophar-
ynx (inner portion of the inferior turbine) and sampled it
more efficiently than the less specific nasal washing. These
more diverse microbiotas could represent established
bacterial communities in the deeper areas of the naso-
pharynx, while the less diverse microbiotas sampled by
nasal washing would correspond to transient bacterial
communities in the nasopharynx.
Conclusions
With the exception of the vagina, explorations of spatial
differences within the human microbiome have been
heavily guided by gross anatomical landmarks and
boundaries [19]. As a result, microenvironments within
otherwise homogenous-appearing human organs, and
especially within spatially constrained sites (like the
nasopharynx), have been relatively ignored. This report
is a first attempt to characterize the nasopharyngeal
microbiotas of asthmatic children at a finer spatial scale.
It identified distinct microbial signatures in NB and NW
samples, which may be due to the distinct microenviron-
ments sampled or the sampling approach itself. Future
microbial studies need to be aware of the potential for
spatial variation (biogeography) in the nasopharynx and
choose the best sampling approach to target the nasal
areas of interest. Our next goal is to characterize the
nasopharyngeal microbiome in more depth by brushing
the nasal vestibule and turbinates (inferior, middle, and
superior) to distinguish resident from transient bacteria.
Then, we will use this information to compare nasal,
oral, and tracheal microbiotas, so airway microbial dy-
namics during asthma can be better understood.
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